These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19037991)

  • 1. DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells.
    Qiu H; Yashiro M; Shinto O; Matsuzaki T; Hirakawa K
    Cancer Sci; 2009 Jan; 100(1):181-8. PubMed ID: 19037991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergic antiproliferative effect of DNA methyltransferase inhibitor in combination with anticancer drugs in gastric carcinoma.
    Zhang X; Yashiro M; Ohira M; Ren J; Hirakawa K
    Cancer Sci; 2006 Sep; 97(9):938-44. PubMed ID: 16805821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of radiosensitivity by 5-Aza-CdR through activation of G2/M checkpoint response and apoptosis in osteosarcoma cells.
    Li Y; Geng P; Jiang W; Wang Y; Yao J; Lin X; Liu J; Huang L; Su B; Chen H
    Tumour Biol; 2014 May; 35(5):4831-9. PubMed ID: 24474250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
    Karpf AR; Moore BC; Ririe TO; Jones DA
    Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of 5-Aza-2'-deoxycytidine on human nasopharyngeal carcinoma xenograft in nude mice].
    Zhang S; Kong WJ; Wang YJ; Han YC; Zhang D
    Ai Zheng; 2005 Oct; 24(10):1201-5. PubMed ID: 16219133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
    Mirza S; Sharma G; Pandya P; Ralhan R
    Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
    Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K
    Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma.
    Xiao WH; Sanren GW; Zhu JH; Li QW; Kang HR; Wang RL; Song LP; Ye M
    World J Gastroenterol; 2010 May; 16(19):2371-7. PubMed ID: 20480522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].
    Du HL; Qi Y; Shi YJ; Bu DF; Wu SL
    Ai Zheng; 2002 Oct; 21(10):1057-61. PubMed ID: 12508642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-Aza-CdR on the proliferation of human breast cancer cell line MCF-7 and on the expression of Apaf-1 gene.
    Xiong H; Qiu H; Zhuang L; Xiong H; Jiang R; Chen Y
    J Huazhong Univ Sci Technolog Med Sci; 2009 Aug; 29(4):498-502. PubMed ID: 19662370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 5-Aza-2'-deoxycytidine on expression of PP1γ in learning and memory.
    Zhang Z; Yang J; Liu X; Jia X; Xu S; Gong K; Yan S; Zhang C; Shao G
    Biomed Pharmacother; 2016 Dec; 84():277-283. PubMed ID: 27665473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Aza-2'-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status.
    Liu J; Zhang Y; Xie YS; Wang FL; Zhang LJ; Deng T; Luo HS
    Oncol Rep; 2012 Aug; 28(2):545-52. PubMed ID: 22664909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells.
    Yashiro M; Qiu H; Hasegawa T; Zhang X; Matsuzaki T; Hirakawa K
    Br J Cancer; 2011 Nov; 105(10):1522-32. PubMed ID: 21997136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of 5-Aza-2'-deoxycytidine against gastric cancer involves DNA damage in an ATM-P53 dependent signaling pathway and demethylation of P16(INK4A).
    Liu J; Xie YS; Wang FL; Zhang LJ; Zhang Y; Luo HS
    Biomed Pharmacother; 2013 Feb; 67(1):78-87. PubMed ID: 23201008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells.
    Kim JG; Bae JH; Kim JA; Heo K; Yang K; Yi JM
    PLoS One; 2014; 9(8):e105405. PubMed ID: 25136811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2'-deoxycytidine.
    Deng T; Zhang Y
    Life Sci; 2009 Feb; 84(9-10):311-20. PubMed ID: 19159630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.
    Chai G; Li L; Zhou W; Wu L; Zhao Y; Wang D; Lu S; Yu Y; Wang H; McNutt MA; Hu YG; Chen Y; Yang Y; Wu X; Otterson GA; Zhu WG
    PLoS One; 2008 Jun; 3(6):e2445. PubMed ID: 18560576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
    Shen WJ; Dai DQ; Teng Y; Liu HB
    World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
    Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
    Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.